Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Rafael Expands CPI-613 Trial

americanpharmaceuticalreviewDecember 27, 2019

Tag: Rafael , CPI-613 , lymphoma , leukemia , Burkitt

PharmaSources Customer Service